SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is drawing attention after a recent rebound that traders say held its gains, with bullish technical setups and positioning ahead of earnings. The upbeat view contrasts with concerns that high rates and a sluggish housing market could continue to weigh on renovation demand.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers sharp rally to fresh multi-year highs is drawing attention, with traders citing rotation into defensive, dividend-paying pharma stocks and positioning ahead of the quarterly report. Bulls see a technical breakout and pipeline momentum, while skeptics warn the move may meet resistance and point to patent-expiration and growth concerns.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 77,397.34014094 USD and is up 0.28 over the last 24 hours. It is currently trading on 12773 active market(s) with $12,152,377,915.37 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoin is drawing attention amid concerns over Binances reported major hack and paused withdrawals, with traders debating whether damaged exchange trust could trigger further selling. Others argue the market is absorbing the shock and point to Binances reported reimbursement progress and planned withdrawal reopening as reasons for optimism.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Attention centers on expected Q3 results and the Phase 3 QUILT-2.005 topline for ANKTIVA plus BCG in BCG-naive bladder cancer; the trial is database-locked, with a supplemental filing planned if results support it. Bullish traders see the readout and ANKTIVAs expanded bladder-cancer label as growth catalysts, while others question commercial uptake and point to competition, short-selling, and broader market weakness to explain the volatility.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is drawing attention as traders use the leveraged inverse Nasdaq ETF to hedge or bet on further weakness in tech, citing concerns about AI spending and valuations alongside recent tech-led selling. The community is divided: some expect more downside, while others warn that rumors of a U.S.Iran deal and a possible market rebound could reverse gains in the short ETF.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow is being discussed amid volatile, uneven trading across major indexes, with traders watching Fed policy and rising Treasury yields as pressures on equities. Some see relative strength in the Dow as money rotates away from tech, while others warn that inflation, oil-market risks and weakening momentum could deepen a selloff.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Discussion centers on BioCrysts upcoming quarterly results and whether continued ORLADEYO growth can support the stock despite its weak performance. Traders are also looking ahead to Navenibart and Netherton data, while debating managements acquisition strategy and expressing frustration over dilution and limited shareholder returns; buyout talk remains speculative.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results and outlook are drawing attention, with traders highlighting stronger streaming profitability and resilient theme-park performance. The reaction is mixed: some see support for a turnaround, while others point to the stocks persistent range-bound price action and difficulty holding gains.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention ahead of its upcoming earnings report, with traders watching whether guidance holds and how management addresses pressure on the pharmacy benefit management business. Some see the recent pullback as a potential technical rebound setup, while others remain cautious after the stocks recent selling.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has lifted UVIX, drawing traders seeking a hedge against a broader market pullback. The community is split between expecting volatility to persistciting concerns about oil, interest rates and geopolitical risksand warning that UVIX can quickly lose value as volatility fades and its leveraged futures exposure decays.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nano-X Imaging (NASDAQ: NNOX) Advances Its Mission to Expand Access to Medical Imaging

Access to medical imaging remains an important consideration for healthcare systems, particularly in underserved regions where equipment, infrastructure and trained personnel may be limited. While conventional X-rays play an essential role in diagnostic care, their two-dimensional images can make certain anatomical details more difficult to distinguish when structures overlap. In some healthcare settings, rising imaging [&#8230;]

Nano-X Imaging (NASDAQ: NNOX) Subsidiary Signs Distribution Agreement to Commercialize HealthOST in Italy

Nanox (NASDAQ: NNOX) announced that its subsidiary, Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is intended to expand Nanox AI commercial presence in the Italian market, leveraging Technologic experience and local [&#8230;]

Finding What the Scan Already Captured: Nanox Advances Its AI Business on Two Fronts

A CT scan ordered to answer one clinical question may capture additional anatomical information beyond the original indication. In certain cases, routine CT imaging can include information related to the spine, coronary arteries, liver and other areas, creating an opportunity to support clinical evaluation of findings that may otherwise go unnoticed. Nano-X Imaging Ltd. (NASDAQ: [&#8230;]

Nanox’s Integrated Imaging Ecosystem: Expanding Access to 3D Imaging and Diagnostics

Nano-X Imaging Ltd. (NASDAQ: NNOX) is approaching that problem from a different direction. Rather than building another high-end system for major hospitals, Nanox is assembling an integrated platform intended to extend medical imaging into outpatient facilities, clinics and other settings where conventional advanced imaging infrastructure is difficult to justify. Nanox.ARC: Expanding Access to 3D Imaging [&#8230;]

Nano-X Imaging (NASDAQ: NNOX) Signs Nanox.ARC Distribution Agreement for Costa Rica

Nanox (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier [&#8230;]

Full Transcript: Nano X Imaging Q2 2026 Earnings Call

On Wednesday, Nano X Imaging (NASDAQ:NNOX) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensiveread more...

Nano-X Imaging (NASDAQ: NNOX) Expands Nanox.ARC Distribution in New England

Nanox (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., entered into a distribution agreement with Associated X-Ray Imaging Corp. to support deployment of the Nanox.ARC across New England. Under the agreement, Associated X-Ray Imaging will market, distribute and support the FDA-cleared, multisource 3D digital tomosynthesis system, leveraging its regional customer relationships and service infrastructure. [&#8230;]

Nano-X Imaging (NASDAQ: NNOX) to Report Second-Quarter 2026 Financial Results Sept. 9

Nanox (NASDAQ: NNOX), an innovative medical imaging technology company, announced it will report financial results for the quarter ended June 30, 2026, before market open on Sept. 9, 2026. CEO and Acting Chairman Erez Meltzer and CFO Guy Nathanzon will host a conference call beginning at 8:30 a.m. ET to review the results and provide [&#8230;]

Nano-X Imaging (NASDAQ: NNOX) Is ‘One to Watch’

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to… Read […]

NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm PR Newswire NEW YORK, Aug. 11, 2026...

Nano-X Imaging Ltd. engages in the development of medical imaging systems. It operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.

Nano X Imaging Ltd

Nano X Imaging Jumps To 4-Month High On FDA Green Light For X-Ray System: Retail In Frenzy

Equity

Bullish Sentiment

Shares of Nano-X Imaging Ltd. surged by as much as 10% on Thursday, reaching levels not seen since August before pulling back slightly.&nbsp;The medical imaging device company announced it had received 510(k) clearance from the U.S. Food and Drug Administration for its Nanox.ARC, a stationary X-ray system designed to produce tomographic images for a range of general use cases.&nbsp;These include imaging of the human musculoskeletal system, lungs, abdomen, and sinuses, serving as an adjunct to conventional radiography for adult patients.“With this FDA clearance, we can now offer U.S. healthcare providers significantly broader imaging capabilities that are akin to commonly used traditional X-ray devices,” said Erez Meltzer, CEO and Acting Chairman of Nano-X.&nbsp;“Our mission is to provide healthcare practices with a transformative imaging advantage with the Nanox.ARC - an accessible, cost-effective solution that not only provides advanced diagnostic imaging capabilities but also elevates overall patient care.”The company is optimistic that the new FDA-cleared indications will facilitate the broader commercial expansion of Nanox.ARC in the U.S., where the system is already deployed in multiple healthcare facilities across seven states.<figure class="image"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_05_at_10_24_00_PM_1b7d74dac3.png" alt="Screenshot 2024-12-05 at 10.24.00 PM.png" width="1318" height="318"><figcaption>NNOX sentiment and message volume on Dec 5 as of 11:45 am ET | Source: Stocktwits</figcaption></figure>Retail sentiment for Nano-X on Stocktwits has exploded, with over 16,000 followers turning ‘extremely bullish’ in response to the news.&nbsp;One user said they have “been waiting for this moment for four years.”<stembedurl>https://stocktwits.com/True_Value_Seeker/message/595191815</stembedurl>Another user speculated on the possibility of acquisition based on the regulatory approval.<stembedurl>https://stocktwits.com/redceedar/message/595190307</stembedurl>The company is also generating buzz due to its attendance at a Cantor Fitzgerald meeting in New York on Thursday.&nbsp;Despite a recent downgrade, with Cantor lowering its price target from $14 to $11, the brokerage maintained an ‘Overweight’ rating following Nano-X’s third-quarter (Q3) results.&nbsp;Nano-X reported $3 million in Q3 revenue, below consensus estimates, but revealed notable growth in teleradiology services and AI solutions. Analysts remain optimistic about expanding U.S. deployments and the potential for additional indications and next-gen devices.NNOX shares have remained nearly flat year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail sentiment for Nano-X on Stocktwits has exploded, with over 16,000 followers turning ‘extremely bullish’ in response to the news.

The company is optimistic that the new FDA-cleared indications will facilitate the broader commercial expansion of Nanox.ARC in the U.S.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.3301
Prev Close	$0.3058
Open	$0.2972
Dividend Yield	0.00%
50-Day Moving Average	$0.6326
Beta	1.88
Avg. Volume	1.46M
PE Ratio	-0.19

52-Week High	$4.71
52-Week Low	$0.2793
Market Capitalization	$25.94M
EPS (Annual)	-$1.16
Price to Book	0.32
Revenue Per Employee	$66,096.45

Feed

News

Sentiment

Earnings

Fundamentals

Info

NNOX Fundamentals